A US Food and Drug Administration (FDA) site inspection at the Philips Medical Systems manufacturing facility in Cleveland revealed inadequate handling of thousands of customer complaints, as well as ...
The Food and Drug Administration issued a warning letter to Philips citing significant violations at three of its medical device facilities. The inspections took place between January and March 2025 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Philips Medical Systems employs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results